Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

NHSX announced digital products supported by a new elective recovery tech fund in England

11 Jan 2022

In December 2021, NHSX announced that the new elective recovery tech fund would support over 400 innovative digital technologies. The fund has been established to help NHS organizations accelerate the uptake of digitally supported elective care. Up to £250 million has been made available to Integrated Care Systems as a part of a £700 million Targeted Investment Fund intended to speed up elective recovery and tackle waiting lists.

Supported products are considered for use in the following areas:

  • Early discharge and home rehabilitation;
  • Home-based pre-surgical support;
  • Productivity benefits;
  • Patient portal and record sharing;
  • Real-time operational data or population health management tool;
  • Robotic process automation;
  • Streamline elective administrative processes;
  • Support people at home;
  • Remote consultations.

The full list of technologies can be found here.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).